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The most appropriate surgical management of “follicular neoplasm/suspicious for follicular neoplasm”
lesions, is still controversial. Analysing and comparing the experience of two units for endocrine surgery,
we retrospectively evaluated 721 patients, surgically treated after a follicular neoplasm diagnosis. Total
thyroidectomy was routinely performed in one Institution, while in the other one it was selectively
carried out. The main criteria leading to hemythyroidectomy were a single nodule, the age 45 years, the
absence of thyroiditis or clinical/intraoperative suspicion of malignancy.
Total thyroidectomy was performed in 402/721 patients (55.7%), hemythyroidectomy in 319/721 cases
(44.2%) and a completion thyroidectomy in 51/319 cases (15.9%). The overall malignancy rate was 24%
(176/721 patients), respectively 16% (51/319 patients) following hemythyroidectomy, and 31% (125/402
patients) following total thyroidectomy. Deﬁnitive recurrent laryngeal nerve paralysis and permanent
hypoparathyroidism were not reported in hemythyroidectomy patients in which lower mean hospital-
ization and costs were observed. Considering the low-risk of follicular neoplasm solitary lesions,
hemythyroidectomy is still the safest standard of care with lower hospitalization and costs. In case of
multiglandular disease or thyroiditis, that might be associated with a higher risk of cancer, total thy-
roidectomy should be recommended. Further investigation is warranted to achieve a better preoperative
follicular neoplasm diagnostic accuracy in order to reduce the amount of unnecessary surgical operations
with a diagnostic aim.
© 2014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
In the last decade, the extensive use of thyroid ultrasound (US)
guided FNC (ﬁne needle cytology), has determined a surprisingly
increased detection of differentiated cancer and in about 15e30% of
cases of “follicular neoplasm/suspicious for follicular neoplasm”
lesions (FN), whose undetermined nature requires pathologic ex-
amination [1e4]. Papillary variants are the most frequent thyroid
neoplasms, followed by follicular, medullary cancer, often part of
the MEN-2 syndrome [5,6], and anaplastic carcinoma, associatedzo).
f of Surgical Associates Ltd.with an unfavourable prognosis similar to that observed in sarco-
matoid carcinomas of other districts [7]. The recent National Cancer
Institute “Thyroid FNA Conference” speciﬁed consistent criteria to
diagnose FNs, in most cases including lesions such as hyperplastic
nodular goiter (HN), or follicular adenoma (FA) [8]. Identiﬁcation of
capsular or vascular invasion is necessary to achieve a deﬁnitive
diagnosis and less frequently a well differentiated thyroid carci-
noma, papillary thyroid cancer (PTC), typically in its follicular
variant (FVPTC) and less commonly follicular carcinoma (FTC), is
postoperatively diagnosed [1]. According to literature data, the
increased number of FN diagnoses has led to more thyroid surgical
procedures, demonstrating that malignancy rate (MR) associated
with FN is low (10e30%) [8,9]. Nonetheless, neither preoperative
US features nor molecular markers, nor intra-operative
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increased number of diagnostic thyroidectomies have been re-
ported. On the other hand, in several patients who underwent lo-
bectomy, a completion thyroidectomy was required. Despite
several studies, management guidelines are controversial, endo-
crine, head and necks surgeons are divided between supporters
and detractors of routine total thyroidectomy (TT), and FN surgical
treatment differs from one institution to another. HT was consid-
ered as an adequate procedure in 96% of FN cases [11] and more-
over, according to American Thyroid Association (ATA) guidelines,
thanks to its limited operative risks, is well indicated in the treat-
ment of small (<1 cm), low-risk, unifocal, intrathyroidal papillary
carcinomas, in absence of clinical lymph nodes metastases [12]. On
the contrary, the frequent presence of a contralateral occult
microcarcinoma, the increased healthcare costs in managing the
remnant lobe and increasing complication rates of reinterventions
are the main arguments evocated in favour of TT, the operation of
choice in most thyroid diseases [13e16]. Available evidence data
conﬁrm the need of a better preoperative evaluation of patients
with a FN to avoid unnecessary diagnostic surgery. Analysing the
data reported in one of the largest reported series and describing
the results of a multicentric study by two academic Units of
endocrine surgery, this controversial issue is here investigated. In
addition, a review of more recent literature papers was performed.
The analysis of different surgical procedures e TT vs HT e and
histological outcomes was the main objective of the study.
2. Study design
We analysed, by a retrospective multicenter study, the clinical
experience of two university Units of endocrine surgery, of Sarde-
gna and Campania, at medium risk for thyroid cancer. 800 patients
(pts) treated between January 2000 and December 2008, after
cytological evidence of FN, were selected by computerized search.
All patients provided written consent for the treatment of data. In
order to uniform the different classiﬁcation adopted for all the
FNCs, a centralized review, conducted by two experienced endo-
crine pathologists of the Cytology Service of Biomorphologic and
Functional Sciences Department of “Federico II” University of
Naples and of Department of Cytomorphology of University of
Cagliari, using at least two smear layers for each case, was per-
formed. The Bethesda NCI Conference criteria for FN were adopted:
a moderate/high cellularity, the microfollicular pattern in a little or
absent colloid background were the main diagnostic criteria.
Conversely, cells with overlapping and crowding patterns, and/or
nuclear atypia (vesicular nuclei, micro nucleoli and irregular cell
membrane), which raised the suspect for PTC, were excluded. Age,
gender, associated thyroiditis and nodule sizewere compared along
with deﬁnitive pathology. Pathological examination, surgical
complications and long-term progression of the remnant lobe
represent the main parameters of this analysis. Our aim was to
identify the most appropriate surgical treatment and the most
reliable predictive criteria of malignancy.
3. Materials and methods
From 800 selected pts, only 721 cases, 524 female (72.6%), 197
male (27.3%) with a mean age of 47.93 years, fully responding to the
reported criteria according to study design, were included in the
series. In Institution A (VII Division of General and Endocrine Sur-
gery e Second University of Naples, Italy) TT was performed in
bilateral thyroid disease cases or in patients with high-risk clinical
features (thyroiditis, ﬁxity or inﬁltration of cervical structures) and
familiarity with thyroid cancer (154/721). A single nodule, the age
45 years, the absence of thyroiditis or radiological, clinical andintraoperative suspicion of malignancy were the main criteria
leading to HT (319/721). Frozen section examination was not per-
formed, and in case of cancer conﬁrmed by deﬁnitive pathology,
completion thyroidectomy was undertaken. In Institution B
(Department of Surgical Sciences University of Cagliari, Italy),
TT was routinely performed and frozen section examination was
not used (248/721). An intraoperative nerve monitoring was not
utilized. Routine pre and post-operative ﬁbrolaryngoscopy
was performed; vocal fold paresis was considered deﬁnitive (pa-
ralysis) 6 months after surgery. Serum calcium (normal
value ¼ 2.09e2.54 mmol/L) and iPTH (intact parathyroid hormone)
levels (normal value ¼ 1.06e6.89 pmol/L) were dosed on post-
operative day 1. An iPTH serum level <1.06 pmol/L was considered
for postoperative hypoparathyroidism (deﬁnitive 6 months after
surgery). After HT, levothyroxine was administered in the majority
of cases (mean dose 75 ± 25 mg).
3.1. Statistical analysis
Data were analysed using descriptive statistics: for the cate-
gorical variables, the Pearson chi-squared (exact) test and, for the
quantitative variables, the independent t-Student test was used.
Datawere reported as the mean value ± standard error of the mean
(SEM). All calculations were performed using the software package
GraphPad Prism, Version 5.0 forWindows (GraphPad Software, San
Diego, CA, USA). Our values were considered statistically signiﬁcant
if p was 0.05.
4. Results
4.1. Cyto-histological correlation
Institution A: HN was diagnosed in 172 (36.4%) cases at the
pathological examination, FA in 211 (44.7%) cases, whereas malig-
nancywas diagnosed in 89/472 pts (18.8%) (Fig.1). PTCwas found in
69/89 (77.5%). Most of the PTC cases were follicular variant subtype
(58/69). 15/89 (16.8%) patients were diagnosed of FTC, whereas in 5
(5.6%) cases were Hürthle cell carcinoma.
Institution B: HN was diagnosed in 107 (42.9%) cases at the
pathological examination, FA in 55 (22.1%) cases, whereas malig-
nancy was diagnosed in 87/249 patients (34.9%) (Fig. 1). PTC was
found in 67/87 (77%); 32/67 belonged to the follicular variant
subtype. 17/87 (19.5%) patients were diagnosed of FTC, whereas 2
(2.3%) cases were Hürthle cell carcinoma.
4.2. Clinical data and histological diagnosis
Institution A: Thyroiditis co-existed in 99/472 pts (21%). It was
associated with cancer in 17 pts (17/89; 19%) while to benign pa-
thology in 82/383 pts (21.4%). Mean age of 37.8 ± 14.1 years, female
gender (F/M ¼ 6.4/1), and a mean nodule size of 16.4 ± 6.9 mm
were associated to malignancy. While patients affected by benign
disease are characterized by a mean age of 47.3 ± 12.5 year and a
mean nodule size of 16.9 ± 7.6 mm, with a female/male ratio of
1.85/1. Age <40 years and female gender were statistically associ-
ated to malignancy (Table 1)
Institution B: Thyroiditis co-existed in 119/249 pts (47.7%). It was
associated with cancer in 40 patients (40/87; 45.9%) and to benign
pathology in 79/162 patients (48.7%). A solitary FN lesion was
diagnosed in only 140/249 patients (56.2%), while in the remaining
cases a multinodular disease or thyroiditis were associated. In
cancer patients mean age of 51.5 ± 14.9 years, female gender (F/
M ¼ 4.11/1), and a mean nodule size of 18.6 ± 11.4 mm were
associated to malignancy. In patients affected by benign disease, a
mean age of 52.9 ± 12.9 year and a mean nodule size of
Fig. 1. Relationship between surgical treatment and histological diagnosis of 721 FN patients.
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None of the characteristics was associated to malignancy with a
statistical signiﬁcance (Table 2)
4.3. Surgical treatment and histological diagnosis
Institution A: HT was performed in 318/472 (67.3%) pts,
including 239 female (75.2%), 79 male (24.8%), with a mean age of
43.4 ± 13.8 years. Histology revealed HN in 121/318 (38%), FA in
146/318 (46%), including 8 Hürthle cell FA, and 51/318 (16%) can-
cers; these latters underwent completion thyroidectomy (Fig. 1). TT
was performed in 154/472 (32.6%) pts, 87 female (56.5%), 67 male
(43.5%), with a mean age of 49.9 ± 11.1 years. Histology showed HN
in 51/154 (33.1%), FA in 65/154 (42.2%), including 8 Hürthle cell FA,
and 38/154 (24.6%) carcinomas.
Institution B: TT was performed in 248/249 (99.6%) patients, HT
in 1/249 (0.4%, that resulted FA at the pathological examination).
HN was diagnosed in 107 (42.9%) cases, FA in 55 (22.1%) cases,
whereas malignancy was diagnosed in 87/249 patients (34.9%)
(Fig. 1). Considering the MR and surgical operation in a high rate of
patients affected by a solitary FN nodule TT could be considered as
an overtreatment.
4.4. Surgical treatment and outcomes
Institution A: Deﬁnitive complications were not observed after
HT (Table 3). Conversely, 2 TT cases reported deﬁnitive recurrent
laryngeal nerve (RLN) paralysis (1.3%). RLN transient paresis rates
were similar between HT (1.2%; 4/318 pts) and TT (3.2%; 5/154 pts)
(p ¼ 0.13). On the contrary, we reported a transient hypoparathy-
roidism in HT (1.2%; 4/318 pts), lower than in TT (8.4%; 13/154 pts;
p  0.0001), with a statistically signiﬁcant difference. Permanent
hypoparathyroidism occurred after TT in 1.94% (3/154 pts). A cer-
vical haematoma occurred in 3/318 HT (0.9%) and in 2/154 TTTable 1
Clinical and pathological data of Institution A patients.
Benign pathology
(383/472 pts)
Cancer (89/472 pts) p
Age (years)a 47.3 ± 12.5 37.8 ± 14.1 <0.05
Female/Male ratio 1.8 6.4 0.001
Tumour size (mm)a 16.9 ± 7.6 16.4 ± 6.9 n.s.
Associated thyroiditis 21.4% 19% n.s.
p  0.05 was considered statistically signiﬁcant.
n.s. ¼ not signiﬁcant.
pts ¼ patients.
a Mean value ± standard deviation.(1.3%); of these latter, only one case required reintervention for
bleeding control. Wound infection only occurred in one HT patient
(0.3%). Mean hospitalization was 1.9 ± 0.7 days for HT and 3.2 ± 1.3
for TT and was associated with lower costs in HT group (p < 0.001).
Institution B: RLN transient paresis rates were 0.8% (2/249 pts).
Permanent hypoparathyroidism occurred in 1.6% (4/249 pts). A
cervical haematoma occurred in 3/249 HT (1.2%); of these, 2 cases
required reintervention for bleeding control. Wound infection only
occurred in one patient (0.4%) (Table 4).
4.5. Completion thyroidectomies
Institution A: a completion thyroidectomy was performed
whenever (n ¼ 51) pathology revealed malignancy on the HT sur-
gical specimen, that was a microcarcinoma in 6/51 cases (11.7%);
themean time between HTand second surgerywas 35.1days± 14.1.
Preoperative ultrasound features “suspected” for cancer (margins
features, vascularization, microcalciﬁcations) have been identiﬁed
in 16/51 pts (31.3%). Apart from only one (1.9%) transient RLN
paresis, no relevant complications occurred. Histological exami-
nation showed PTC in 5 (9.8%) cases, with microcarcinomas in most
cases (4/5). In benign HT (n¼ 267), after a 88.2 ± 30.4monthsmean
follow-up, data showed contralateral nodular relapse in 18 cases
(5.6%). Compressive symptoms led to surgical removal; histological
examination showed HN in all cases, which was associated to
thyroiditis in one case.
4.6. Comparison between the two institutions
Patient characteristics of the two institutions differ signiﬁcantly
(Table 4). Differences in Female/Male Ratio, age, incidence of
thyroiditis and of malignancy were statistically signiﬁcant. In
particular, the incidence of carcinoma was signiﬁcantly higher in
the institution B (34.9% vs 18.8%, p < 0.01 (0.000002)). Moreover, in
the latter the incidence of thyroiditis (47.7% vs 21%, p < 0.01) wasTable 2
Clinical and pathological data of institution B patients.
Benign pathology
(162/249 pts)
Cancer (87/249 pts) p
Age (years)a 52.9 ± 12.9 51.5 ± 14.9 0.19
Female/male ratio 3.7 4.1 0.91
Tumour size (mm)a 17.9 ± 9.1 18.6 ± 11.4 0.27
Associated thyroiditis 48.7% 45.9% 0.77
p  0.05 was considered statistically signiﬁcant.
pts ¼ patients.




Transient hypopara 1.3 8.4 <0.0001
Permanent hypopara e 1.9 e
Transient RLN palsy 1.3 3.2 0.13
Permanent RLN palsy e 1.3 e
Cervical haematoma 0.9 1.2 0.7
Wound infection 0.3 e e
HT: hemithyroidectomy; TT: total thyroidectomy; Hypopara: hypoparathyroidism.
RLN: recurrent laryngeal nerve.
p  0.05 was considered statistically signiﬁcant.
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(52.4 ± 13.6 years vs 45.5 ± 13.3, p < 0.01 (0.0000000003)) and this
could also explain the higher incidence of cancer.
5. Discussion
This study analyses two different surgical procedurese TT vs HT
e in FN patients. According to our knowledge, the presented series
is one of the largest reported. The overall MR associated with un-
determined FNCs was low (24%, 176/721 cases), resulting signiﬁ-
cantly different between the considered regions, respectively
higher in Sardegna (34.9%) than in Campania (18.9%), and in TT than
in HT group. Nevertheless, considering the low MR following
routine TT, this surgical approach may represent an “over-
treatment” in a high number of cases. Two elements have to be
certainly underlined: Sardegna has proved to be an area of endemic
goiter and presents a very high incidence of autoimmune diseases,
in particular Hashimoto's thyroiditis, probably determining a more
elevated rate of malignant neoplasms, justifying the wide diffusion
of TT. Therefore, the characteristics of the population at risk and the
clinic-pathological features of cancer itself may be signiﬁcantly
different according to ethnicity and geographical location [17]. The
cytological classiﬁcation may not be uniform in different
geographical areas and therefore a centrally review of all FNCs was
systematically performed. The age<40 years and female gender
resulted statistically associated with cancer in Institution A, while it
was not conﬁrmed in the other institution. Therefore, the most
effective surgical procedure following FN diagnosis is still contro-
versial and, analysing the preoperative predictive value of several
clinical, radiological and molecular variables, the debate is not
solved [18e20].
In the last decades an increasing precocious diagnosis of “low-
risk” thyroid carcinomas (<2 cm) and microcarcinomas has been
reported and more favourable oncological outcomes are expected
[21]. So, planning a multimodal therapeutic protocol, an “over-
treatment” with risk of morbidity should be avoided suggesting a
“tailored” and less “aggressive” management [16]. Nevertheless,
according to available evidence data, HT and TT maintain both an
important role in the current approach to thyroid neoplasms,Table 4
Comparison between clinico-pathological data of FN patients observed at the two
different Institutions.
Institution A Institution B p
Patient number 472 249 e
Female/male ratio 2.23 3.88 <0.01
Age (years)a 45.5 ± 13.3 52.4 ± 13.6 <0.01
Associated thyroiditis (%) 21 47.8 <0.01
Tumour size (mm)a 16.8 ± 7.5 18.1 ± 9.9 >0.05
Malignancy disease (%) 18.9 34.9 <0.01
p  0.05 was considered statistically signiﬁcant.
a Mean ± standard deviation.remaining matter of intensive research [22]. In case of small
(1 cm) FN solitary low-risk lesions, HT, avoiding the possibility of
bilateral recurrent laryngeal nerve paresis and deﬁnitive lifelong
opotherapy, may represent the most accurate procedure [23] and
the safest standard of care [1]. In our series, a low associated MR, a
low long-term incidence of completion thyroidectomy (5.6%), and
ﬁnally a low rate of contralateral unexpected PTC (9.8%) in HT pa-
tients were observed. Moreover, in case of small papillary cancers
(<1 cm), the need of TT remains controversial. Revised ATA
guidelines consider HT a sufﬁcient treatment for incidental, small
(<1 cm), low-risk, unifocal, intrathyroidal papillary carcinomas, in
absence of clinical lymph nodes metastases [12]. Our series
conﬁrmed the absence of deﬁnitive complications, also following a
completion thyroidectomy, the lower mean hospitalization and
costs in the HT group. Transient recurrent nerve paralysis was
similar in the two groups of patients while transient hypopara-
thyroidism ratewas lower following HT. According to literature, the
majority of FNs are diagnosed as benign, and it may be considered
that most patients could beneﬁt more from a watchful waiting
rather than from surgery. A surgical treatment performed only for a
diagnostic purpose increases healthcare costs, may cause distress to
patients and can be a source of litigations. On the contrary, TT,
associated with a low morbidity rate, similar to that reported in
parathyroid surgery [24e27], should be recommended both in
patients affected by multinodular pathology and in cases of
thyroiditis, as frequently reported in Sardegna, where a more
elevated cancer risk has been observed. Furthermore the presence
of contralateral occult microcarcinoma, described with a different
incidence in various series, the increased healthcare costs in
managing the remnant lobe and increasing complication rates of
reinterventions are evocated in favour of TT [15,28,29]. Moreover,
the performance of TT associated with prophylactic central
compartment neck dissection in clinically node-negative patients is
still debated [30]. Further randomized prospective trials could
contribute to the standardization of cytologic classiﬁcations and
treatment proﬁles, identifying the patients risk and the best sur-
gical procedure. Moreover, sex, age, lesion size, serum thyroglob-
ulin levels, US ﬁndings, molecular and genetic markers have been
intensively investigated in making management decisions but the
analysis of available evidence data supply controversial results. In
the attempt to better classify thyroid nodules a more accurate US
assessment (echogenicity, margins features, vascularization,
microcalciﬁcations, elastography) is promising, but not still deﬁn-
itively diagnostic [3,9,31]. Similarly, most of the proposed immu-
nocytochemical (galectin 3, CK19 and HBME-1), genetic markers
(BRAF, RET/PTC, PAX 8/PPRY and NRAS) or thyroglobulin serum
level, may be very useful, but not widely validated [2,32e39]. The
choice of the most suitable surgical procedure is also related to
many different parameters, and a multifactorial clinical analysis,
similar to that considered for differentiated thyroid cancer [40],
could be useful. Nevertheless, each single factor did not reach
predictive power and, moreover clinical series are unfortunately
retrospective. Historical high-risk ﬁndings such as hoarseness of
the voice, nodule ﬁxation to the surrounding structures or previous
exposure to radiations are rarely observed; more attention should
be focused on patient age, sex or nodule size. Our data showed a
difference in predictive factors. In one Institution the age >50 years
was related with cancer, while in the other, the age <40 years and
female gender were statistically associated to malignancy. Tyler,
Davis [40] and Baloch [41], suggested thyroidectomy in >50 years
old patients, conversely to the evidence reported by other authors
[23,42,43]. Several studies highlighted the inﬂuence of the hard
consistency on clinical palpation and the US hypoechoic pattern
[44] on cancer risk. In our series, a cancer mean size less than
20 mm was observed even if according to literature data nodules
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lesions [8,41,43e45]. These clinical features still remain a contro-
versial issue [41,9]. Even if the series is one of the largest reported,
according to the high number of cases and the long-term follow-up,
the different FN surgical approach of the two Institutions and the
different epidemiological and pathological features of the analysed
patients were the main limitations of the retrospective study.
Nevertheless, it should be considered an outcomes analysis of
surgical treatment in FN patients with different characteristics
rather than a comparison between two different surgical pro-
cedures (HT vs TT) performed in similar cases.
6. Conclusions
Deﬁnitive FN MR was low and most surgical procedures had
only a diagnostic signiﬁcance. MR was higher after TT, especially in
patients with thyroiditis. Even if some clinical features were cancer
associated, malignancy could not be reliably predicted before
surgery.
In solitary small low-risk lesions, HT, thanks to its lower
complication rates, is still the safest standard of care, avoiding
unnecessary morbidity. In our series in HT patients a lower mean
hospital stay and costs were also reported.
TT should be recommended in case of multiglandular disease or
in presence of thyroiditis that might be associated with a higher
risk of cancer.
Even if a more conservative surgical approach might be sug-
gested in FN patients, more prospective randomized trials based on
multi-institutional, and multivariate analysis are requested to
achieve a better preoperative diagnostic accuracy reducing the
amount of unnecessary surgical operations with a diagnostic aim.
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